TCT-501 A propensity-matched study comparing overlapping bioresorbable scaffolds versus new generation everolimus eluting stents.

MLA

Panoulas, Vasileios F., et al. “TCT-501 A Propensity-Matched Study Comparing Overlapping Bioresorbable Scaffolds versus New Generation Everolimus Eluting Stents.” Journal of the American College of Cardiology (JACC), vol. 66, Oct. 2015, p. B205. EBSCOhost, https://doi.org/10.1016/j.jacc.2015.08.518.

APA

Panoulas, V. F., Kawamoto, H., Sato, K., Miyazaki, T., Naganuma, T., Chieffo, A., Carlino, M., Montorfano, M., Latib, A., & Colombo, A. (2015). TCT-501 A propensity-matched study comparing overlapping bioresorbable scaffolds versus new generation everolimus eluting stents. Journal of the American College of Cardiology (JACC), 66, B205. https://doi.org/10.1016/j.jacc.2015.08.518

Chicago

Panoulas, Vasileios F., Hiroyoshi Kawamoto, Katsumasa Sato, Tadashi Miyazaki, Toru Naganuma, Alaide Chieffo, Mauro Carlino, Matteo Montorfano, Azeem Latib, and Antonio Colombo. 2015. “TCT-501 A Propensity-Matched Study Comparing Overlapping Bioresorbable Scaffolds versus New Generation Everolimus Eluting Stents.” Journal of the American College of Cardiology (JACC) 66 (October): B205. doi:10.1016/j.jacc.2015.08.518.